2002
DOI: 10.1038/sj.onc.1205911
|View full text |Cite
|
Sign up to set email alerts
|

The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells

Abstract: Differential gene expression of cell lines derived from a malignant melanoma or its autologous lymph node metastasis using cDNA arrays indicated down-regulation of PRSS11, a gene encoding the serine protease HtrA1, a homolog of the Escherichia coli protease HtrA, in the metastatic line. Stable PRSS11 overexpression in the metastatic cell line strongly inhibited proliferation, chemoinvasion and Nm23-H1 protein expression in vitro, as well as cell growth in vivo in nu/nu mice. A polyclonal anti-HtrA1 serum demon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
187
0
2

Year Published

2005
2005
2013
2013

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 185 publications
(196 citation statements)
references
References 29 publications
(27 reference statements)
7
187
0
2
Order By: Relevance
“…22 Other groups have used microarrays to analyze the gene expression profile of melanoma vs dysplastic nevi 23 or to determine which genes are operative in the transformation from localized to metastatic melanoma. [24][25][26][27][28] As expected, the progression from radial to vertical growth phase is associated with loss of cell cycle regulatory control. For example, cyclin D1 is expressed in radial growth phase melanoma and is lost in progression to vertical growth phase neoplasms, while p16 (INK4A) and p27 (KIP1) expression are diminished in advanced melanoma.…”
Section: Molecular Adjuncts To Diagnosis: the Microarraysupporting
confidence: 55%
See 1 more Smart Citation
“…22 Other groups have used microarrays to analyze the gene expression profile of melanoma vs dysplastic nevi 23 or to determine which genes are operative in the transformation from localized to metastatic melanoma. [24][25][26][27][28] As expected, the progression from radial to vertical growth phase is associated with loss of cell cycle regulatory control. For example, cyclin D1 is expressed in radial growth phase melanoma and is lost in progression to vertical growth phase neoplasms, while p16 (INK4A) and p27 (KIP1) expression are diminished in advanced melanoma.…”
Section: Molecular Adjuncts To Diagnosis: the Microarraysupporting
confidence: 55%
“…31 In addition to WNT5A, other genes are implicated in the acquisition of cell motility and angiogenesis. 25,26,[32][33][34] Hypoxia-inducible genes such as Cyr61 have shown to be constitutively upregulated in late stage melanoma. 35 Complementary to cDNA microarray is the tissue microarray.…”
Section: Molecular Adjuncts To Diagnosis: the Microarraymentioning
confidence: 99%
“…The expression of HtrA1 and HtrA3 is decreased in several cancers, while overexpression of HtrA1 in human cancers inhibits cell growth and proliferation (91)(92)(93)(94). These results suggest a tumor suppressor function for HtrA proteinases.…”
Section: High-temperature Requirement Proteinasesmentioning
confidence: 88%
“…HTRA2 is the best characterized of the four and exists as a membrane protein primarily involved in mitochondrial quality control [2,3]. Both HTRA1 and HTRA2 are primarily regarded as being key regulators of tumor development and subsequent malignancies [4][5][6], although a growing body of evidence now exists to suggest that HTRA1 may also play a central role in musculoskeletal development and disease through its proteolytic actions on proteins within the extracellular matrix (ECM) [7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%